Aura Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
31.75
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.52
|
0.00
|
0.52
|
100.00%
|
|
2022-12-31
|
-0.51
|
0.00
|
0.51
|
100.00%
|
|
2022-09-30
|
-0.51
|
-0.54
|
-0.03
|
-5.88%
|
|
2022-06-30
|
-0.46
|
-0.46
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.44
|
-0.44
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.39
|
-2.51
|
-2.12
|
-543.59%
|
|
2021-09-30
|
-0.45
|
-0.25
|
0.20
|
44.44%
|
|
2021-03-31
|
0.00
|
-28.52
|
-28.52
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.44
|
|
2021-12-31
|
-31.28
|
|
2020-12-31
|
-76.04
|
|
2019-12-31
|
-27.27
|